News
Consolidation in psychedelics as atai pairs with Beckley
UK psychedelic medicines developer Beckley Psytech has agreed to be …
20942 items found
Oncology
Supercharging clinical trials with data and AI: Realyze’s Aaron Brauser on faster, smarter design
Optimising clinical trial screening requires clinical expertise and, …
News
BioNTech flips its cancer bispecific to BMS for a big profit
Bristol Myers Squibb has reached for its wallet to avoid being left …
News
ASCO 25: AZ pitches upfront oral SERD use in breast cancer
AstraZeneca wants to make its oral selective oestrogen receptor …
News
23andMe founder isn't giving up her bid to regain control
Anne Wojcicki has asked the judge in bankruptcy proceedings for …
News
Sanofi draws up $9.1bn plan to buy Blueprint Meds
Sanofi has bolstered its rare disease business with an agreement to …
Oncology
Life beyond lung cancer: Johnson & Johnson’s Breathtaking vision at ASCO 2025
As ASCO 2025 commenced in Chicago on Friday 30th May, pharmaphorum …
News
ASCO 25: Gilead eyes first-line use of Trodelvy in TNBC
Gilead Sciences' TROP2-targeting drug Trodelvy is already used as a …
News
ASCO 25: Regeneron hails Libtayo's adjuvant data in CSCC
Regeneron's PD-1 inhibitor Libtayo could find wider use for a form of …
News
ASCO 25: Braftovi shows "unprecedented" survival gain
A combination regimen based on Pfizer's BRAF inhibitor Braftovi …
R&D
Bringing patients to research centres: Using AI to bring efficiencies forward
Trends can be predicted, and trends can unfold. Here, Liz Beatty – …
Oncology
Innovation, real-world data, and precision medicine: Pierre Fabre and the lung cancer space
As ASCO 2025 kicks off in Chicago, pharmaphorum looks back to a …
News
Consolidation in psychedelics as atai pairs with Beckley
Beckley Psytech has agreed to merge with atai Life Sciences in a deal that would bring together two psychedelic medicine pioneers.
Market Access
Sponsored
Bridging research and clinical guidelines – interactive stra...
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
R&D
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
R&D
Life Sciences Industry Report - Biologics and Generics
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Oncology
Supercharging clinical trials with data and AI: Realyze’s Aa...
At ASCO 2025, Realyze CEO Aaron Brauser talks transforming clinical trial screening with AI, NLP and real-world data use.
Oncology
Life Sciences Industry Report - Oncology
Developments in the oncology space in 2024 brought hope to both industry and patients.
Digital
Partner Content
Axtria Ignite 2025: Leading in an Agentic Era
Axtria’s flagship event is almost here! Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at Forrestal in New Jersey. This
Patients
Partner Content
Operationalize: Expanded Access Programs comes to the West C...
Improving Global Access to Life-Changing Therapeutics...